The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Furosemide, sold under the brand name Lasix among others, is a medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease.
The global Furosemide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Furosemide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Furosemide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Furosemide include Sanofi Aventis, US Pharm Holdings, Mylan, Sandoz, Hospira, West-Ward Pharms, Ivax Sub Teva Pharms, Emcure Pharms and Sun Pharm Inds, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Furosemide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Furosemide.
Report Scope
The Furosemide market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Furosemide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Furosemide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Sanofi Aventis
- US Pharm Holdings
- Mylan
- Sandoz
- Hospira
- West-Ward Pharms
- Ivax Sub Teva Pharms
- Emcure Pharms
- Sun Pharm Inds
Segment by Type
- Injection
- Solution
- Tablet
Segment by Application
- Hospital
- Pharmacy
- Clinics
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Furosemide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Furosemide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Furosemide Market Overview
1.1 Product Overview and Scope of Furosemide
1.2 Furosemide Segment by Type
1.2.1 Global Furosemide Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Solution
1.2.4 Tablet
1.3 Furosemide Segment by Application
1.3.1 Global Furosemide Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinics
1.3.5 Others
1.4 Global Furosemide Market Size Estimates and Forecasts
1.4.1 Global Furosemide Revenue 2019-2030
1.4.2 Global Furosemide Sales 2019-2030
1.4.3 Global Furosemide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Furosemide Market Competition by Manufacturers
2.1 Global Furosemide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Furosemide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Furosemide Average Price by Manufacturers (2019-2024)
2.4 Global Furosemide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Furosemide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Furosemide, Product Type & Application
2.7 Furosemide Market Competitive Situation and Trends
2.7.1 Furosemide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Furosemide Players Market Share by Revenue
2.7.3 Global Furosemide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Furosemide Retrospective Market Scenario by Region
3.1 Global Furosemide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Furosemide Global Furosemide Sales by Region: 2019-2030
3.2.1 Global Furosemide Sales by Region: 2019-2024
3.2.2 Global Furosemide Sales by Region: 2025-2030
3.3 Global Furosemide Global Furosemide Revenue by Region: 2019-2030
3.3.1 Global Furosemide Revenue by Region: 2019-2024
3.3.2 Global Furosemide Revenue by Region: 2025-2030
3.4 North America Furosemide Market Facts & Figures by Country
3.4.1 North America Furosemide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Furosemide Sales by Country (2019-2030)
3.4.3 North America Furosemide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Furosemide Market Facts & Figures by Country
3.5.1 Europe Furosemide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Furosemide Sales by Country (2019-2030)
3.5.3 Europe Furosemide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Furosemide Market Facts & Figures by Country
3.6.1 Asia Pacific Furosemide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Furosemide Sales by Country (2019-2030)
3.6.3 Asia Pacific Furosemide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Furosemide Market Facts & Figures by Country
3.7.1 Latin America Furosemide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Furosemide Sales by Country (2019-2030)
3.7.3 Latin America Furosemide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Furosemide Market Facts & Figures by Country
3.8.1 Middle East and Africa Furosemide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Furosemide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Furosemide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Furosemide Sales by Type (2019-2030)
4.1.1 Global Furosemide Sales by Type (2019-2024)
4.1.2 Global Furosemide Sales by Type (2025-2030)
4.1.3 Global Furosemide Sales Market Share by Type (2019-2030)
4.2 Global Furosemide Revenue by Type (2019-2030)
4.2.1 Global Furosemide Revenue by Type (2019-2024)
4.2.2 Global Furosemide Revenue by Type (2025-2030)
4.2.3 Global Furosemide Revenue Market Share by Type (2019-2030)
4.3 Global Furosemide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Furosemide Sales by Application (2019-2030)
5.1.1 Global Furosemide Sales by Application (2019-2024)
5.1.2 Global Furosemide Sales by Application (2025-2030)
5.1.3 Global Furosemide Sales Market Share by Application (2019-2030)
5.2 Global Furosemide Revenue by Application (2019-2030)
5.2.1 Global Furosemide Revenue by Application (2019-2024)
5.2.2 Global Furosemide Revenue by Application (2025-2030)
5.2.3 Global Furosemide Revenue Market Share by Application (2019-2030)
5.3 Global Furosemide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Aventis
6.1.1 Sanofi Aventis Corporation Information
6.1.2 Sanofi Aventis Description and Business Overview
6.1.3 Sanofi Aventis Furosemide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Aventis Furosemide Product Portfolio
6.1.5 Sanofi Aventis Recent Developments/Updates
6.2 US Pharm Holdings
6.2.1 US Pharm Holdings Corporation Information
6.2.2 US Pharm Holdings Description and Business Overview
6.2.3 US Pharm Holdings Furosemide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 US Pharm Holdings Furosemide Product Portfolio
6.2.5 US Pharm Holdings Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Furosemide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Furosemide Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Corporation Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Furosemide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz Furosemide Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Hospira
6.5.1 Hospira Corporation Information
6.5.2 Hospira Description and Business Overview
6.5.3 Hospira Furosemide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hospira Furosemide Product Portfolio
6.5.5 Hospira Recent Developments/Updates
6.6 West-Ward Pharms
6.6.1 West-Ward Pharms Corporation Information
6.6.2 West-Ward Pharms Description and Business Overview
6.6.3 West-Ward Pharms Furosemide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 West-Ward Pharms Furosemide Product Portfolio
6.6.5 West-Ward Pharms Recent Developments/Updates
6.7 Ivax Sub Teva Pharms
6.6.1 Ivax Sub Teva Pharms Corporation Information
6.6.2 Ivax Sub Teva Pharms Description and Business Overview
6.6.3 Ivax Sub Teva Pharms Furosemide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ivax Sub Teva Pharms Furosemide Product Portfolio
6.7.5 Ivax Sub Teva Pharms Recent Developments/Updates
6.8 Emcure Pharms
6.8.1 Emcure Pharms Corporation Information
6.8.2 Emcure Pharms Description and Business Overview
6.8.3 Emcure Pharms Furosemide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Emcure Pharms Furosemide Product Portfolio
6.8.5 Emcure Pharms Recent Developments/Updates
6.9 Sun Pharm Inds
6.9.1 Sun Pharm Inds Corporation Information
6.9.2 Sun Pharm Inds Description and Business Overview
6.9.3 Sun Pharm Inds Furosemide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sun Pharm Inds Furosemide Product Portfolio
6.9.5 Sun Pharm Inds Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Furosemide Industry Chain Analysis
7.2 Furosemide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Furosemide Production Mode & Process
7.4 Furosemide Sales and Marketing
7.4.1 Furosemide Sales Channels
7.4.2 Furosemide Distributors
7.5 Furosemide Customers
8 Furosemide Market Dynamics
8.1 Furosemide Industry Trends
8.2 Furosemide Market Drivers
8.3 Furosemide Market Challenges
8.4 Furosemide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
